Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Available by prescription, each plan is customized by your provider based on your health history, goals, tolerance, and dosing needs
We do not have comparative data to answer this definitively
In the STEP UP trial, adults living with obesity who received semaglutide 7.2mg achieved an average weight loss of 18.7% over 72 weeks, compared with 15.6% with 2.4mg and 3.9% with placebo
This goes beyond simple wound closure to actual functional restoration
The recent Semaglutide Cardiovascular Outcomes Trial (SOUL) reported that once-daily oral semaglutide (maximal dose, 14 mg), in addition to standard care, significantly reduces the risk of MACE in individuals with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, without an increase in the incidence of serious adverse events [6]
